Method of predicting risk of lung cancer recurrence, and a composition, kit and microarray for the same
US7585634B2 · kind B2 · utility
14Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2008 |
| Grant date | Sep 8, 2009 |
| Priority date | — |
| Expiry date | Jan 9, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/792
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided is a method of predicting risk of lung cancer recurrence in a lung cancer patient or after a patient has lung cancer treatment, the method including: obtaining a biological sample from a lung cancer patient; measuring an expression level of at least one marker gene from the biological sample, the marker gene being selected from the group consisting of marker genes of Table 1, 2 or 3, to obtain data for the expression level of the marker gene; and determining whether the expression level of the marker gene corresponds to an expression level of a recurrence group or an expression level of a non-recurrence group.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.